| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), ZTS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 105.1K | - | - | |
| Dir | 28.4K | - | - | |
| Dir | 27.9K | $2.11M | - | |
| CFO | 22.1K | - | - | |
| VP | 15.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2019 | Chen Heidi C.47 | Executive Vice President | Sale+OE | 11,425 | $119.67 | $1,367,229.75 | -49.9% | |
| Nov 21, 2019 | Fenton Andrew | Executive Vice President | Sell | 12,705 | $120.30 | $1,528,411.50 | -37.1% | |
| Nov 19, 2019 | Alaix Juan Ramon | Chief Executive Officer | Sale+OE | 50,000 | $119.13 | $5,956,500.00 | -34.2% | |
| Nov 19, 2019 | Lagano Roxanne70 | Executive Vice President | Sale+OE | 4,463 | $118.99 | $531,052.37 | -13.4% | |
| Nov 18, 2019 | Chen Heidi C.47 | Executive Vice President | Sale+OE | 11,425 | $118.86 | $1,357,975.50 | -49.9% | |
| Nov 14, 2019 | Lewis Clinton A. Jr.46 | Executive Vice President | Sale+OE | 6,123 | $116.13 | $711,063.99 | -16.7% | |
| Nov 12, 2019 | Peck Kristin C67 | Executive Vice President | Sale+OE | 11,500 | $117.16 | $1,347,389.60 | -25.6% | |
| Oct 14, 2019 | Lewis Clinton A. Jr.46 | Executive Vice President | Sale+OE | 6,123 | $128.62 | $787,540.26 | -15.6% | |
| Sep 16, 2019 | Lewis Clinton A. Jr.46 | Executive Vice President | Sale+OE | 6,123 | $120.05 | $735,066.15 | -14.7% | |
| Aug 19, 2019 | Lagano Roxanne70 | Executive Vice President | Sale+OE | 4,463 | $125.99 | $562,293.37 | -13.4% |